grepcent public filings, reorganized for comparison

PHOTRONICS INC (PLAB)

CIK: 0000810136. SIC: 3674 Semiconductors & Related Devices. Latest 10-K as of: 2025-12-17.

SIC breadcrumb: Manufacturing > Electronic And Other Electrical Equipment And Components, Except Computer Equipment > SIC 3674 Semiconductors & Related Devices

SEC company page: https://www.sec.gov/edgar/browse/?CIK=810136. Latest filing source: 0001140361-25-045801.

Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.

At a glance

FY2025 · period end 2025-10-31 · filed 2025-12-17 · accession 0001140361-25-045801 · source: SEC companyfacts

Revenue
849,294,000 USD verified
Net income
136,405,000 USD verified
Assets
1,804,534,000 USD verified
Free cash flow
59,661,000 USD computed
Net margin
16.06% computed
Operating margin
24.51% computed
Revenue YoY
-2.04% computed
ROE
11.62% computed

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

Peer & cluster context

Peer percentile fingerprint

PLAB ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 3674; per-ratio N printed.PLAB ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 3674; per-ratio N printed.RatioPLABPeer medianPercentileNNet margin16.1%4.9%7159Operating margin24.5%3.7%7958Revenue growth-2.0%13.0%1861FCF margin7.0%10.0%4160ROE11.6%3.8%6858ROA7.6%1.6%7361Liabilities / equity0.180.512259Current ratio5.373.098061

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC industry 3674 Semiconductors & Related Devices, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

Selected Fundamentals

MetricValueUnitFYFiled
Revenue849,294,000USD20252025-12-17
Net income136,405,000USD20252025-12-17
Assets1,804,534,000USD20252025-12-17

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2025-12-17. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000810136.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric2016201720182019202020212022202320242025
Revenue450,678,000535,276,000550,660,000609,691,000663,761,000824,549,000892,076,000866,946,000849,294,000
Net income46,200,00013,130,00042,055,00029,793,00033,820,00055,449,000118,786,000125,485,000130,688,000136,405,000
Operating income52,475,00031,868,00065,627,00052,121,00063,928,00094,554,000211,866,000253,050,000221,518,000208,161,000
Gross profit118,706,00091,315,000131,503,000120,841,000134,654,000167,044,000294,213,000336,162,000315,946,000299,830,000
Diluted EPS0.640.190.590.440.520.891.942.032.092.28
Operating cash flow122,137,00096,833,000130,567,00068,386,000143,046,000150,772,000275,187,000302,176,000261,444,000247,798,000
Capital expenditures50,147,00091,965,00092,585,000178,375,00070,815,000109,099,000112,338,000131,295,000130,942,000188,137,000
Share buybacks0.000.0023,111,00021,696,00034,394,00048,249,0002,522,0000.000.0097,422,000
Assets987,988,0001,020,794,0001,110,009,0001,118,665,0001,188,182,0001,294,202,0001,315,830,0001,526,221,0001,712,059,0001,804,534,000
Liabilities162,514,000155,499,000205,440,000207,573,000225,916,000293,640,000253,741,000250,612,000231,300,000207,227,000
Stockholders' equity710,363,000744,564,000759,671,000769,892,000804,962,000823,692,000831,527,000975,008,0001,120,864,0001,173,589,000
Cash and cash equivalents314,074,000308,021,000329,277,000206,530,000278,665,000276,670,000319,680,000499,292,000598,485,000492,256,000
Free cash flow71,990,0004,868,00037,982,000-109,989,00072,231,00041,673,000162,849,000170,881,000130,502,00059,661,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric2016201720182019202020212022202320242025
Net margin2.91%7.86%5.41%5.55%8.35%14.41%14.07%15.07%16.06%
Operating margin7.07%12.26%9.47%10.49%14.25%25.69%28.37%25.55%24.51%
Return on equity6.50%1.76%5.54%3.87%4.20%6.73%14.29%12.87%11.66%11.62%
Return on assets4.68%1.29%3.79%2.66%2.85%4.28%9.03%8.22%7.63%7.56%
Liabilities / equity0.230.210.270.270.280.360.310.260.210.18
Current ratio5.435.492.632.813.503.133.334.245.075.37

Industry Peer Context

Each number-line places PLAB against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

Net margin peer context

PLAB Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 59.PLAB Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 59.59 SIC peersMin -101.6%Median 4.9%Max 57.7%PLAB 16.1%

Operating margin peer context

PLAB Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 58.PLAB Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 58.58 SIC peersMin -148.7%Median 3.7%Max 60.5%PLAB 24.5%

ROE peer context

PLAB ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 58.PLAB ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 58.58 SIC peersMin -146.9%Median 3.8%Max 76.3%PLAB 11.6%

ROA peer context

PLAB ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 61.PLAB ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 61.61 SIC peersMin -95.6%Median 1.6%Max 58.1%PLAB 7.6%

Financial Bridges

Waterfall figures reconcile reported SEC companyfacts components. Missing bridges are omitted when required components are not present for the same fiscal year.

Income statement bridge from reported figures

PLAB FY2025 income statement bridge from reported figures.PLAB FY2025 income statement bridge from reported figures.PLAB income bridgeFY2025: revenue to net incomeSource: SEC companyfacts FY2025.Income statement bridgeReported amount$0.0B$500.0M$1.0B$849.3MRevenue-$549.5MCost$299.8MGross-$91.7MOpEx$208.2MOperating-$71.8MOther/tax$136.4MNet income

Figure provenance: SEC companyfacts FY 2025. Revenue: accession 0001140361-25-045801; concept RevenueFromContractWithCustomerExcludingAssessedTax; source concepts us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Gross profit: accession 0001140361-25-045801; concept GrossProfit; source concepts us-gaap:GrossProfit | Operating income: accession 0001140361-25-045801; concept OperatingIncomeLoss; source concepts us-gaap:OperatingIncomeLoss | Net income: accession 0001140361-25-045801; concept NetIncomeLoss; source concepts us-gaap:NetIncomeLoss

Free cash flow = operating cash flow - capital expenditures

PLAB FY2025 free cash flow bridge from reported figures.PLAB FY2025 free cash flow bridge from reported figures.PLAB free cash flow bridgeFY2025: operating cash flow less capital expendituresSource: SEC companyfacts FY2025.Free cash flow bridgeReported amount$0.0B$125.0M$250.0M$247.8MOperating cash flow-$188.1MCapex$59.7MFree cash flow

Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0001140361-25-045801; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001140361-25-045801; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0001140361-25-045801; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Financial Charts

PLAB revenue, last 5 periods. Source: SEC companyfacts FY2025.PLAB revenue, last 5 periods. Source: SEC companyfacts FY2025.PLAB RevenueLatest point: FY2025 = $849.3MSource: SEC companyfacts FY2025.Fiscal yearReported revenue$0.0B$500.0M$1.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

PLAB net income, last 5 periods. Source: SEC companyfacts FY2025.PLAB net income, last 5 periods. Source: SEC companyfacts FY2025.PLAB Net incomeLatest point: FY2025 = $136.4MSource: SEC companyfacts FY2025.Fiscal yearNet income$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

PLAB operating income, last 5 periods. Source: SEC companyfacts FY2025.PLAB operating income, last 5 periods. Source: SEC companyfacts FY2025.PLAB Operating incomeLatest point: FY2025 = $208.2MSource: SEC companyfacts FY2025.Fiscal yearOperating income$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: OperatingIncomeLoss. Source concepts: us-gaap:OperatingIncomeLoss.

PLAB gross profit, last 5 periods. Source: SEC companyfacts FY2025.PLAB gross profit, last 5 periods. Source: SEC companyfacts FY2025.PLAB Gross profitLatest point: FY2025 = $299.8MSource: SEC companyfacts FY2025.Fiscal yearGross profit$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: GrossProfit. Source concepts: us-gaap:GrossProfit.

PLAB diluted eps, last 5 periods. Source: SEC companyfacts FY2025.PLAB diluted eps, last 5 periods. Source: SEC companyfacts FY2025.PLAB Diluted EPSLatest point: FY2025 = $2.28/shareSource: SEC companyfacts FY2025.Fiscal yearDiluted EPS (USD/share)$0.00/share$2.00/share$4.00/shareFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

PLAB operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.PLAB operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.PLAB Operating cash flowLatest point: FY2025 = $247.8MSource: SEC companyfacts FY2025.Fiscal yearOperating cash flow$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

PLAB capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.PLAB capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.PLAB Capital expendituresLatest point: FY2025 = $188.1MSource: SEC companyfacts FY2025.Fiscal yearCapital expenditures$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

PLAB share buybacks, last 5 periods. Source: SEC companyfacts FY2025.PLAB share buybacks, last 5 periods. Source: SEC companyfacts FY2025.PLAB Share buybacksLatest point: FY2025 = $97.4MSource: SEC companyfacts FY2025.Fiscal yearShare buybacks$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: PaymentsForRepurchaseOfCommonStock. Source concepts: us-gaap:PaymentsForRepurchaseOfCommonStock.

PLAB assets, last 5 periods. Source: SEC companyfacts FY2025.PLAB assets, last 5 periods. Source: SEC companyfacts FY2025.PLAB AssetsLatest point: FY2025 = $1.8BSource: SEC companyfacts FY2025.Fiscal yearAssets$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: Assets. Source concepts: us-gaap:Assets.

PLAB liabilities, last 5 periods. Source: SEC companyfacts FY2025.PLAB liabilities, last 5 periods. Source: SEC companyfacts FY2025.PLAB LiabilitiesLatest point: FY2025 = $207.2MSource: SEC companyfacts FY2025.Fiscal yearLiabilities$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

PLAB stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.PLAB stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.PLAB Stockholders' equityLatest point: FY2025 = $1.2BSource: SEC companyfacts FY2025.Fiscal yearStockholders' equity$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

PLAB cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.PLAB cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.PLAB Cash and cash equivalentsLatest point: FY2025 = $492.3MSource: SEC companyfacts FY2025.Fiscal yearCash and cash equivalents$0.0B$375.0M$750.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

PLAB free cash flow, last 5 periods. Source: SEC companyfacts FY2025.PLAB free cash flow, last 5 periods. Source: SEC companyfacts FY2025.PLAB Free cash flowLatest point: FY2025 = $59.7MSource: SEC companyfacts FY2025.Fiscal yearFree cash flow$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

As-reported value updates

No tracked differences above grepcent's stated thresholds and capped precision rule were found between the earliest XBRL-filed value and the value currently on file for the standardized annual metrics grepcent tracks.

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-09-10. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000810136.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2023-Q12023-01-290.23reported discrete quarter
2023-Q22023-04-300.65reported discrete quarter
2023-Q32023-07-300.44reported discrete quarter
2023-Q42023-10-31227,473,00044,611,000derived Q4 = FY annual - nine-month YTD
2024-Q12024-01-28216,334,00026,180,0000.42reported discrete quarter
2024-Q22024-04-28217,000,00036,251,0000.58reported discrete quarter
2024-Q32024-07-28210,984,00034,388,0000.55reported discrete quarter
2024-Q42024-10-31222,628,00033,869,000derived Q4 = FY annual - nine-month YTD
2025-Q12025-02-02212,138,00042,851,0000.68reported discrete quarter
2025-Q22025-05-04210,992,0008,861,0000.15reported discrete quarter
2025-Q32025-08-03210,394,00022,891,0000.39reported discrete quarter
2025-Q42025-10-31215,770,00061,801,000derived Q4 = FY annual - nine-month YTD
2026-Q12026-02-01225,066,00042,939,0000.74reported discrete quarter
2026-Q22026-05-03209,940,00031,429,0000.54reported discrete quarter
2026-Q32026-08-02216,047,00028,916,0000.49reported discrete quarter

Quarterly Charts

PLAB quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q3.PLAB quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q3.PLAB Quarterly RevenueLatest point: 2026-Q3 = $216.0MSource: SEC companyfacts 2026-Q3.Fiscal quarterQuarterly Revenue$0.0B$125.0M$250.0M2023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q22026-Q3

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-08-02; accession 0001140361-26-036138; filed 2026-09-10. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

PLAB quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q3.PLAB quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q3.PLAB Quarterly Net incomeLatest point: 2026-Q3 = $28.9MSource: SEC companyfacts 2026-Q3.Fiscal quarterQuarterly Net income$0.0B$125.0M$250.0M2023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q22026-Q3

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-08-02; accession 0001140361-26-036138; filed 2026-09-10. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

PLAB quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q3.PLAB quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q3.PLAB Quarterly Diluted EPSLatest point: 2026-Q3 = $0.49/shareSource: SEC companyfacts 2026-Q3.Fiscal quarterQuarterly Diluted EPS (USD/share)$0.00/share$0.50/share$1.00/share2023-Q12023-Q22023-Q32024-Q12024-Q22024-Q32025-Q12025-Q22025-Q32026-Q12026-Q22026-Q3

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-08-02; accession 0001140361-26-036138; filed 2026-09-10. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Business

Read PLAB's verbatim Item 1 Business section from its latest 10-K: Business.

Risk Factors

Read PLAB's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.

Latest quarter (10-Q)

Latest 10-Q source: 0001140361-26-036138.

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Published MD&A gate trimmed front/tail over-capture. Confidence: high. Filing date: 2026-09-10. Report date: 2026-08-02.

Item 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

Management’s
discussion and analysis (“MD&A”) of the Company’s financial condition and
results of operations should be read in conjunction with its condensed
consolidated financial statements and related notes. Various sections of this
MD&A contain forward-looking statements, all of which are presented based
on current expectations, which may be adversely affected by uncertainties and
risk factors (presented throughout this filing and in the Company’s Form 10-K
for fiscal year 2025), that may cause actual results to materially differ from
these expectations. See “Cautionary Statement Regarding Forward-Looking
Statements”.

We
sell substantially all of our photomasks to designers and manufacturers of IC
and FPD electronic devices. Photomask technology is also being applied to the
fabrication of other high-technology products including advanced packaging
modules, micro-optical components for applications such as virtual
reality/augmented reality and silicon photonics, micro-electronic mechanical
systems (MEMS), and diverse nanotechnology applications. Our selling cycle is
tightly interwoven with the development and release of new semiconductor and
display designs and applications, particularly as they relate to the
semiconductor industry's migration to more advanced design nodes and
fabrication processes. The demand for photomasks is primarily correlated with
new product design activity and to a lesser extent scaling up of manufacturing
of end products. Consequently, an increase in semiconductor or display sales
does not always result in a corresponding increase in photomask sales. To the
extent integrated circuit and flat panel display applications rely less on new
design activity, it could result in a reduction in demand for photomasks. In
addition, new design methodologies driving a reduction in complexity of
photomasks could also reduce demand for photomasks ‒ even if the demand for
semiconductors and FPDs increases. More broadly, advances in semiconductor,
display, and photomask design and production methods that shift the burden of
achieving device performance away from lithography could also reduce the demand
for photomasks. While there is no indication today that such diminishing of
long-range photomask demand is occurring or will occur, the microelectronics
industry has been volatile, experiencing periodic downturns and slowdowns in
design activity. These negative trends have been characterized by, among other
things, diminished product demand, excess production capacity, and accelerated
erosion of selling prices with a concomitant effect on revenue and
profitability.

We are typically required to fulfill customer orders within a short period of time, sometimes within twenty-four hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for IC photomasks and two to three weeks of backlog for FPD photomasks. However, the demand for some IC photomasks can extend longer than the traditional time period; thus, for some products, our backlog can expand to as long as two to three months.

The global semiconductor and FPD industries are driven by end markets which have broad application in the global economy including but not limited to consumer-driven applications, data centers that support AI implementation, electric vehicles and national security. While we cannot predict the timing of the industry's transition to volume production of next-generation technology nodes, or the timing of up and down-cycles with precise accuracy, we believe that such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these environments is dependent upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.

We are focused on improving our competitiveness by advancing our technology and reducing costs and, in connection therewith, have invested and plan to continue to invest in manufacturing equipment to serve both the high-end and mainstream photomask markets. As we face challenges that require us to make significant improvements in our competitiveness, we continue to implement programs to streamline, drive efficiency and reduce costs in our infrastructure.

State-of-the-art
production for semiconductor masks is considered to be 4 or 5 nanometer and
smaller including EUV lithography for ICs and Generation 8.6 AMOLED
display-based process technologies for FPDs. However, we define our high-end
product category as 28nm and below for semiconductors and Generation 10.5 plus,
Generation 6 and 8 AMOLED and LTPS for displays. This is consistent with
current merchant mask industry definitions. Moreover, design nodes above 28nm
and FPD processes for standard LCD displays below Generation 10 are considered
mainstream or standard products. At these geometries and various high-end
nodes, we can produce full lines of photomasks, and there is no significant
technology employed by our competitors that is not available to us. We expect
advanced node designs to continue to move to production throughout fiscal 2026,
and we believe we are well positioned to service an increasing volume of this
business as a result of our investments in manufacturing processes and
technology in the regions where our customers are located.

25

Table of Contents

The
photomask industry has been and is expected to continue to be characterized by
technological change and evolving industry standards. In order to remain
competitive, we will be required to continually anticipate, respond to, and
utilize changing technologies. In particular, we believe that, as semiconductor
geometries continue to become smaller and/or more complex, and display designs
become larger or otherwise more advanced, we will be required to manufacture
even more complex products, including photomasks with advanced optical
proximity correction, increase of curvilinear patterning and EUV photomasks.
Additionally, demand for photomasks has been, and could in the future be,
adversely affected by changes in high-performance electronics fabrication
methods that affect the type or quantity of photomasks used, such as changes in
semiconductor demand that favor programmable IC devices and other approaches
that replace application-specific ICs, or the use of certain chip-stacking
methodologies that lessen the emphasis on conventional lithography technology.
Furthermore, increased market acceptance of alternative methods of transferring
circuit designs onto semiconductor wafers could reduce or eliminate the need
for photomasks in the production of semiconductors.

Our
revenues have benefited, and our costs, including depreciation, have been
affected by the increased demand for high-end-technology photomasks that
require more advanced manufacturing capabilities, but generally command higher
ASPs. Our year-to-date capital expenditure payments were $130.4 million and
$120.6 million in the nine months ended August 2, 2026 and the nine months
ended August 3, 2025, respectively. Nonetheless, we intend to continue to make
the required investments to support the technological and production
requirements of our customers that we believe will continue to enable our
growth. This includes investments to replace end-of-life mask-making equipment
with higher-performing systems that better serve our customers. In support of
this effort, we expect capital expenditure payments to be in the range of $255
million to $305 million in fiscal year 2026.

The
manufacture of photomasks for use in fabricating ICs, FPDs, and other related
products built using comparable photomask-based process technologies has been,
and continues to be, capital intensive. Our employees and our integrated global
manufacturing network represent a significant portion of our fixed operating
cost base. Should our revenue decrease as a result of a decrease in design
releases from our customers, we may have excess or underutilized production
capacity, which could significantly impact our operating margins, or result in
write-offs from asset impairments.

Results of Operations

All
the following tabular comparisons, unless otherwise indicated, are for the
three months ended August 2, 2026, May 3, 2026 and August 3, 2025 and the nine
months ended August 2, 2026 and August 3, 2025.

The
analysis and tables in this MD&A section may not foot due to rounding.

The
following tables present selected operating information expressed as a
percentage of revenue.

Three Months EndedNine Months Ended
August 2, 2026May 3, 2026August 3, 2025August 2, 2026August 3, 2025
Revenue100.0%100.0%100.0%100.0%100.0%
Cost of goods sold66.868.766.366.864.6
Gross profit33.231.333.733.235.4
Selling, general, and administrative10.49.98.89.98.8
Research and development1.71.32.01.42.0
Operating income21.120.122.921.924.6
Other income (expense), net4.35.6(4.5)6.3(1.6)
Income before income tax provision25.425.718.428.123.0
Income tax provision5.15.14.65.55.4
Net income20.320.613.822.617.6
Net income attributable to noncontrolling interests6.95.63.06.85.8
Net income attributable to Photronics, Inc. shareholders13.4%15.0%10.9%15.9%11.8%

26

Table of Contents

Revenue

Our quarterly revenues can be affected by the seasonal purchasing practices of our customers. As a result, demand for our products is typically impacted during the first quarter of our fiscal year by the North American, European, and Asian holiday periods, as some of our customers may adjust their buying activities during those periods.

The
following tables present changes in revenue disaggregated by product type and
geographic origin.

Changes in Revenue by Product Type ($ in millions)

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: 0001140361-25-045801. The complete FY 2025 MD&A is published at /company/PLAB/mda/fy2025/.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2025-12-17. Report date: 2025-10-31.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following should be read in conjunction with “Cautionary Statement Regarding Forward Looking Statements” and our combined consolidated financial statements and notes thereto included in Part II,
Item 8 of this Annual Report on Form 10-K.

For a comparison of results of operations for the fiscal years ended October 31, 2024 and 2023, see Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of
Operations of Photronics Inc.’s Annual Report on Form 10-K for the fiscal year ended October 31, 2024, filed with the SEC on December 19, 2024.

Overview

We sell substantially all of our photomasks to designers and manufacturers of IC and FPD electronic devices.  Photomask technology is also being applied to the fabrication of other high-technology products including
advanced packaging modules, micro optical components for applications such as virtual reality/augmented reality and silicon photonics, micro-electronic mechanical systems (MEMS), and diverse nanotechnology applications. Our selling cycle is
tightly interwoven with the development and release of new semiconductor and display designs and applications, particularly as they relate to the semiconductor industry's migration to more advanced design nodes and fabrication processes. The
demand for photomasks is primarily correlated with new product design activity and to a lesser extent scaling up of manufacturing of end products. Consequently, an increase in semiconductor or display sales does not always result in a
corresponding increase in photomask sales. To the extent integrated circuit and flat panel display applications rely less on new design activity, it could result in a reduction in demand for photomasks. In addition, new design methodologies
driving a reduction in complexity of photomasks could also reduce demand for photomasks ‒ even if the demand for semiconductors and FPDs increases. More broadly, advances in semiconductor, display, and photomask design and production methods that
shift the burden of achieving device performance away from lithography could also reduce the demand for photomasks. While there is no indication today that such diminishing of long range photomask demand is occurring or will occur, the
microelectronics industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These negative trends have been characterized by, among other things, diminished product demand, excess production capacity, and
accelerated erosion of selling prices with a concomitant effect on revenue and profitability.

We are typically required to fulfill customer orders within a short period of time, sometimes within twenty-four hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for IC
photomasks and two to three weeks of backlog for FPD photomasks. However, the demand for some IC photomasks can extend longer than the traditional time period; thus, for some products, our backlog can expand to as long as two to three months.

The global semiconductor and FPD industries are driven by end markets which have broad application in the global economy including but not limited to consumer-driven applications, data centers that support AI
implementation, electric vehicles and national security. While we cannot predict the timing of the industry's transition to volume production of next-generation technology nodes, or the timing of up and down-cycles with precise accuracy, we
believe that such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these environments
is dependent upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.

We are focused on improving our competitiveness by advancing our technology and reducing costs and, in connection therewith, have invested and plan to continue to invest in manufacturing equipment to serve both the
high-end photomask and mainstream markets. As we face challenges that require us to make significant improvements in our competitiveness, we continue to implement programs to streamline, drive efficiency and reduce cost in our infrastructure.

State-of-the-art production for semiconductor masks is considered to be 7 nanometer and smaller including EUV lithography for ICs and Generation 8.6 AMOLED display-based process technologies for FPDs. However, we
define our high-end product category as 28nm and below for semiconductors and Generation 10.5 plus, Generation 6 and 8 AMOLED and LTPS for displays. This is consistent with current merchant mask industry definitions. Moreover, design nodes above
28nm and FPD processes for standard LCD displays below Generation 10 are considered mainstream or standard products. At these geometries and various high-end nodes, we can produce full lines of photomasks, and there is no significant technology
employed by our competitors that is not available to us. We expect advanced-generation designs to continue to move to production throughout fiscal 2026, and we believe we are well positioned to service an increasing volume of this business as a
result of our investments in manufacturing processes and technology in the regions where our customers are located.

24

Table of Contents

The photomask industry has been, and is expected to continue to be characterized by technological change and evolving industry standards. In order to remain competitive, we will be required to continually anticipate,
respond to, and utilize changing technologies. In particular, we believe that, as semiconductor geometries continue to become smaller, and display designs become larger or otherwise more advanced, we will be required to manufacture even more
complex products, including photomasks with optical proximity correction, phase-shift and EUV photomasks. Additionally, demand for photomasks has been, and could in the future be, adversely affected by changes in high-performance electronics
fabrication methods that affect the type or quantity of photomasks used, such as changes in semiconductor demand that favor programmable IC devices and other approaches that replace application-specific ICs, or the use of certain chip-stacking
methodologies that lessen the emphasis on conventional lithography technology. Furthermore, increased market acceptance of alternative methods of transferring circuit designs onto semiconductor wafers could reduce or eliminate the need for
photomasks in the production of semiconductors.

Our revenues have benefited, and our costs, including depreciation, have been affected by the increased demand for high-end-technology photomasks that require more advanced manufacturing capabilities, but generally
command higher ASPs. Our capital expenditure payments were $188.1 million, $130.9 million and $131.3 million in 2025, 2024 and 2023, respectively. Nonetheless, we intend to continue to make the required investments to support the technological and
production requirements of our customers that we believe will continue to enable our growth. This includes investments to replace end-of-life mask-making equipment with higher-performing systems that better serve our customers. In support of this
effort, we expect capital expenditure payments to be approximately $330 million in fiscal year 2026.

The manufacture of photomasks for use in fabricating ICs, FPDs, and other related products built using comparable photomask-based process technologies has been, and continues to be, capital intensive. Our employees and
our integrated global manufacturing network represent a significant portion of our fixed operating cost base. Should our revenue decrease as a result of a decrease in design releases from our customers, we may have excess or underutilized
production capacity, which could significantly impact our operating margins, or result in write-offs from asset impairments.

25

Table of Contents

Results of Operations

The following tables present selected operating information expressed as a percentage of revenue. The columns may not foot due to rounding.

Three Months Ended
October 31, 2025August 3, 2025October 31, 2024
Revenue100.0%100.0%100.0%
Cost of goods sold65.066.363.0
Gross profit35.033.737.0
Selling, general and administrative expenses9.38.89.4
Research and development expenses1.52.02.4
Operating income24.122.925.2
Non-operating (expense) income, net11.1(4.5)(0.5)
Income before income tax provision35.218.424.7
Income tax (benefit) provision(1.2)4.66.5
Net income36.413.818.2
Net income attributable to noncontrolling interests7.83.02.9
Net income attributable to Photronics, Inc. shareholders28.6%10.9%15.3%
Year Ended
October 31, 2025October 31, 2024October 31, 2023
Revenue100.0%100.0%100.0%
Cost of goods sold64.763.662.3
Gross profit35.336.437.7
Selling, general and administrative expenses8.99.07.8
Research and development expenses1.91.91.5
Operating income24.525.628.4
Non-operating income1.63.01.9
Income before income tax provision26.128.530.3
Income tax provision3.77.37.9
Net income22.421.222.4
Net income attributable to noncontrolling interests6.36.18.3
Net income attributable to Photronics, Inc. shareholders16.1%15.1%14.1%

Note: All the following tabular comparisons, unless otherwise indicated, are for the three months ended October 31, 2025 (Q4 FY25), August 3, 2025 (Q3 FY25) and October 31,
2024 (Q4 FY24), and for the fiscal years ended October 31, 2025 (YTD FY25), October 31, 2024 (YTD FY24), and October 31, 2023 (YTD FY23). Please refer to Part II, Item 7 of our 2024 Form 10-K for comparative discussion of our fiscal years ended
October 31, 2024, and October 31, 2023. The tables in this section (Part II, Item 7) may not foot due to rounding.

26

Table of Contents

Revenue

Our quarterly revenues can be affected by the seasonal purchasing practices of our customers. As a result, demand for our products is typically reduced during the first quarter of our fiscal year by the North
American, European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods.

The following tables present changes in revenue disaggregated by product type and geographic origin, in Q4 FY25 and YTD FY25 from revenue in prior reporting periods.

Quarterly Changes in Revenue by Product Type ($ in millions)

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A or browse all MD&A years.

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

Macro cross-references for PLAB

Indicators mapped to this company's SIC classification (industry 3674 Semiconductors & Related Devices) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

Macro-to-micro threads including this sector: Inflation (CPI / PCE / PPI), US labor market, Growth & output, Money & trade, Government finances, Sector employment, Industrial orders & inventories, Trade & external.

All 71 macro indicators →

For LLMs & downloads

Markdown twin: /company/PLAB.md · JSON record: /company/PLAB.json · verified financials: JSON / CSV · concise section index: /llms.txt